510(k) device
Hypnos (369054-200)
Cadwell Industries, Inc. · Automatic Event Detection Software For Polysomnograph With Electroencephalograph (OLZ, Class II) · First FDA decision Dec 14, 2025, newest Dec 14, 2025Sleep apnea
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
3
Naming "Hypnos"
MAUDE reports
0
Brand "Hypnos", since 2015
PubMed studies
36
Mentioning "Hypnos"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Hypnos (369054-200)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 1 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Hypnos", any status and sponsor, newest update first.
University Hospital, LilleAcademic, hospital or other
NCT03711643 · 88 participants · Start May 7, 2019 · Primary completion Oct 26, 2021
Device: hypnosis mask · For: Prostatic Diseases
Sites: Lille, France
IRCCS San RaffaeleAcademic, hospital or other
NCT07279142 · 48 participants (planned) · Start Dec 16, 2025 · Primary completion Nov 13, 2026
Device: Radiofrequency · For: Overactive Bladder (OAB); Incontinence, Urge
Sites: Milan, Italy
Centre Hospitalier de RoubaixAcademic, hospital or other
NCT05352945 · 8 participants · Start Nov 25, 2022 · Primary completion May 23, 2024
Device: HyPNOS self-hypnosis mask from DREAMINZZ · For: Idiopathic Overactive Bladder
Sites: Roubaix, France
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Hypnos", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OLZ
10 reports: 8 malfunction, 1 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Hypnos"[tiab]. The summary above synthesizes these.
- A high-performance fluorescent sensor spatiotemporally reveals cell-type specific regulation of intracellular adenosine in vivo.
Wei Q, Bai Z, Wang L, et al. · Nat Commun · 2025
- Emmanuel Mignot, orexin, and the errors of Hypnos.
Burton A · Lancet Neurol · 2023
- Bacterial homologs of innate eukaryotic antiviral defenses with anti-phage activity highlight shared evolutionary roots of viral defenses.
van den Berg DF, Costa AR, Esser JQ, et al. · Cell Host Microbe · 2024Research Support, Non-U.S. Gov't
- Modeling Patient-Specific Desaturation Patterns in Sleep Apnea.
Guerrero G, Le Rolle V, Loiodice C, et al. · IEEE Trans Biomed Eng · 2022Research Support, Non-U.S. Gov't
- From Hypnos to Ephialtes: waking up to the consequences of accidental awareness during obstetric general anaesthesia.
Palanisamy A, Paech MJ · Anaesthesia · 2021Editorial, Comment
- Hypnos and pasithea in the ICU.
Spronk PE · Crit Care Med · 2013Editorial, Comment
- Disentangling Hypnos from his poppies.
Sleigh J · Anesthesiology · 2010Editorial, Historical Article
- Bacteriophage genomes encode both broad and specific counter-defense repertoires to overcome bacterial defense systems.
Costa AR, van den Berg DF, Esser JQ, et al. · Cell Host Microbe · 2025
- Induction of Dormancy in Cryptococcus neoformans In Vitro: The HypNOS Protocol.
Agrawal R, Sturny-Leclère A, de Castro RJA, et al. · Methods Mol Biol · 2024
- Evaluation of a multisensory hypnosis mask during transrectal ultrasound-guided prostate biopsy: Results of a randomized controlled trial.
Cortes B, Béhal H, Labreuche J, et al. · Fr J Urol · 2026
- Hypnos board: A low-cost all-in-one solution for environment sensor power management, data storage, and task scheduling.
Nguyen B, Goto B, Selker JS, et al. · HardwareX · 2021
Other devices of this type
Also filed under product code OLZ.
- Sleep ProfilerAdvanced Brain Monitoring, Inc. · 510(k) 2016
- Somnum (Somnum)Honeynaps Co., Ltd. · 510(k) 2026
- DeepRESPNox Medical Ehf · 510(k) 2025
- Dreem 3SBeacon Biosignals, Inc. · 510(k) 2024
- EnsoSleepEnsodata, Inc. · 510(k) 2021
- Sleepware G3Respironics, Inc. · 510(k) 2020
- Sleep Analysis ModuleNeurotronics, LLC · 510(k) 2026
- Onera SleepMap (SLEEPMAP)Onera B.V. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.